SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001599298-23-000090
Filing Date
2023-10-16
Accepted
2023-10-16 16:08:25
Documents
1
Period of Report
2023-10-13

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1697486896.html 4  
1 FORM 4 wk-form4_1697486896.xml 4 4220
  Complete submission text file 0001599298-23-000090.txt   5847
Mailing Address 51 ADAM WAY ATHERTON CA 94027
Business Address
Zanganeh Mahkam (Reporting) CIK: 0001507650 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36866 | Film No.: 231327417

Mailing Address 2882 SAND HILL ROAD SUITE 106 MENLO PARK CA 94025
Business Address 2882 SAND HILL ROAD SUITE 106 MENLO PARK CA 94025 617-514-7149
Summit Therapeutics Inc. (Issuer) CIK: 0001599298 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations